Personal tools

DOID:127: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{DOID
{{DOID
|id=DOID:127
|alt_id=
|name=leiomyoma
|namespace=disease_ontology
|def="A cell type benign neoplasm that is a benign tumor of smooth muscle cells." [url:http://en.wikipedia.org/wiki/Cancer, url:http://en.wikipedia.org/wiki/Leiomyoma]
|xref=MSH:D007889;;NCI:C3157;;SNOMEDCT_2010_1_31:189787000;;SNOMEDCT_2010_1_31:189788005;;SNOMEDCT_2010_1_31:189793008;;UMLS_CUI:C0023267
|is_a=DOID:0060084
|synonym="leiomyoma" EXACT [CSP2005:2011-3663];;"leiomyoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189788005];;"leiomyomatous neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189787000];;"leiomyomatous neoplasm NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189793008];;"leiomyomatous tumor" EXACT [NCI2004_11_17:C3157]
|comment=
|comment=
|alt_id=
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def="A cell type benign neoplasm that is a benign tumor of smooth muscle cells." [url:http://en.wikipedia.org/wiki/Cancer, url:http://en.wikipedia.org/wiki/Leiomyoma]
|subset=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=DOID:127
|is_a=DOID:0060084
|is_obsolete=
|located_in=
|located_in=
|name=leiomyoma
|namespace=FANTOM
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|is_obsolete=
|subset=
|preceded_by=
|synonym="leiomyoma" EXACT [CSP2005:2011-3663];;"leiomyoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189788005];;"leiomyomatous neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189787000];;"leiomyomatous neoplasm NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189793008];;"leiomyomatous tumor" EXACT [NCI2004_11_17:C3157]
|union_of=
|xref=MSH:D007889;;NCI:C3157;;SNOMEDCT_2010_1_31:189787000;;SNOMEDCT_2010_1_31:189788005;;SNOMEDCT_2010_1_31:189793008;;UMLS_CUI:C0023267
}}
}}

Latest revision as of 16:48, 12 September 2014

Name:leiomyoma
Namespace:FANTOM
Definition:"A cell type benign neoplasm that is a benign tumor of smooth muscle cells." [url:http://en.wikipedia.org/wiki/Cancer, url:http://en.wikipedia.org/wiki/Leiomyoma]
Xrefs:
links:

MSH:D007889
NCI:C3157
SNOMEDCT_2010_1_31:189787000
SNOMEDCT_2010_1_31:189788005
SNOMEDCT_2010_1_31:189793008

UMLS_CUI:C0023267
Synonyms: "leiomyoma" EXACT [CSP2005:2011-3663]
"leiomyoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189788005]
"leiomyomatous neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189787000]
"leiomyomatous neoplasm NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189793008]
"leiomyomatous tumor" EXACT [NCI2004_11_17:C3157]

Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data


Parents

is_a:DOID:0060084(cell type benign neoplasm)



Children
NA

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

Mouse (Mus musculus)

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:127 (leiomyoma), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data


P-valueFFCPShort description
5.41e-147FFCP PHASE1:Hg19::chr3:132975986..132975997,-#_d00878cb70a4a23c5131b6943b0765cfp1@uc003epl.2
5.41e-147FFCP PHASE2:Hg19::chr3:132975986..132975997,-#_d00878cb70a4a23c5131b6943b0765cfp1@uc003epl.2
8.98e-131FFCP PHASE2:Hg19::chr1:152842532..152842539,+#_d5f96552b89497180c25b346ebe93d92p@chr1:152842532..152842539, +
8.98e-131FFCP PHASE2:Hg19::chr1:152842546..152842554,+#_d5f96552b89497180c25b346ebe93d92p@chr1:152842546..152842554, +
8.98e-131FFCP PHASE1:Hg19::chr1:152842532..152842539,+#_d5f96552b89497180c25b346ebe93d92p@chr1:152842532..152842539, +
8.98e-131FFCP PHASE1:Hg19::chr1:152842546..152842554,+#_d5f96552b89497180c25b346ebe93d92p@chr1:152842546..152842554, +
2.33e-118FFCP PHASE1:Hg19::chr3:132976005..132976010,-#_9bf40fa349115f656b4bdc9ccc25d30ep2@ENST00000505721
2.33e-118FFCP PHASE2:Hg19::chr3:132976005..132976010,-#_9bf40fa349115f656b4bdc9ccc25d30ep2@ENST00000505721
3.48e-118FFCP PHASE2:Hg19::chr2:218192886..218192899,-#_ff735fb53a1d19feda3fd22181f355f4p@chr2:218192886..218192899, -
3.48e-118FFCP PHASE1:Hg19::chr2:218192886..218192899,-#_ff735fb53a1d19feda3fd22181f355f4p@chr2:218192886..218192899, -
5.41e-85FFCP PHASE1:Hg19::chr8:42037558..42037573,-#_7ecf57fa3698bf45966474d02c9482c9p@chr8:42037558..42037573, -
5.41e-85FFCP PHASE2:Hg19::chr8:42037558..42037573,-#_7ecf57fa3698bf45966474d02c9482c9p@chr8:42037558..42037573, -
1.28e-84FFCP PHASE1:Hg19::chr3:141150971..141150978,+#_487f031c75e9a7a312f7aeb33567e9cbp60@ZBTB38
1.28e-84FFCP PHASE2:Hg19::chr3:141150971..141150978,+#_487f031c75e9a7a312f7aeb33567e9cbp60@ZBTB38
2.39e-66FFCP PHASE2:Hg19::chr2:218192853..218192858,-#_ff3c2beaf55be562cd3e69b4377237b8p@chr2:218192853..218192858, -
2.39e-66FFCP PHASE1:Hg19::chr2:218192853..218192858,-#_ff3c2beaf55be562cd3e69b4377237b8p@chr2:218192853..218192858, -
4.68e-66FFCP PHASE1:Hg19::chr1:163045452..163045464,+#_1c13ad77663790a3a38253e55ad2be97p@chr1:163045452..163045464, +
4.68e-66FFCP PHASE2:Hg19::chr1:163045452..163045464,+#_1c13ad77663790a3a38253e55ad2be97p@chr1:163045452..163045464, +
2.43e-60FFCP PHASE2:Hg19::chr22:44708774..44708788,-#_295250bf53da3c337d817eb4c64b03aap3@KIAA1644
2.43e-60FFCP PHASE1:Hg19::chr22:44708774..44708788,-#_295250bf53da3c337d817eb4c64b03aap3@KIAA1644
4.17e-55FFCP PHASE2:Hg19::chr2:207406777..207406786,+#_d94b1a7d87d91e712323cd3c5f525124p9@ADAM23
4.17e-55FFCP PHASE1:Hg19::chr2:207406777..207406786,+#_d94b1a7d87d91e712323cd3c5f525124p9@ADAM23
1.41e-46FFCP PHASE2:Hg19::chr8:42040287..42040298,-#_b29eebabd6265515ddbaaea13ffbe358p10@PLAT
1.41e-46FFCP PHASE1:Hg19::chr8:42040287..42040298,-#_b29eebabd6265515ddbaaea13ffbe358p10@PLAT
9.77e-45FFCP PHASE2:Hg19::chr7:12134329..12134354,-#_58dc3c67aa521508cb1dff4c402b1893p@chr7:12134329..12134354, -
9.77e-45FFCP PHASE1:Hg19::chr7:12134329..12134354,-#_58dc3c67aa521508cb1dff4c402b1893p@chr7:12134329..12134354, -
9.77e-45FFCP PHASE2:Hg19::chr2:218193183..218193196,-#_58dc3c67aa521508cb1dff4c402b1893p@chr2:218193183..218193196, -
9.77e-45FFCP PHASE1:Hg19::chr2:218193183..218193196,-#_58dc3c67aa521508cb1dff4c402b1893p@chr2:218193183..218193196, -
6.94e-44FFCP PHASE1:Hg19::chr6:86200265..86200276,+#_bb26a66b8ecc3d78bd3c2741d64ea1aep@chr6:86200265..86200276, +
6.94e-44FFCP PHASE2:Hg19::chr6:86200265..86200276,+#_bb26a66b8ecc3d78bd3c2741d64ea1aep@chr6:86200265..86200276, +
1.23e-38FFCP PHASE2:Hg19::chrX:7077952..7077959,+#_de6772f1b9d061dba0d0c7245fa3a42cp18@STS
1.23e-38FFCP PHASE1:Hg19::chrX:7077952..7077959,+#_de6772f1b9d061dba0d0c7245fa3a42cp18@STS
1.85e-36FFCP PHASE2:Hg19::chr6:86204236..86204247,+#_0180ed1196b8db329fe57bea66c6751bp@chr6:86204236..86204247, +
1.85e-36FFCP PHASE1:Hg19::chr6:86204236..86204247,+#_0180ed1196b8db329fe57bea66c6751bp@chr6:86204236..86204247, +
2.98e-36FFCP PHASE2:Hg19::chr1:198203826..198203841,+#_72c8e672946ac84378062c62fe9c5680p@chr1:198203826..198203841, +
2.98e-36FFCP PHASE1:Hg19::chr1:198203826..198203841,+#_72c8e672946ac84378062c62fe9c5680p@chr1:198203826..198203841, +
4.66e-34FFCP PHASE1:Hg19::chr13:32313685..32313699,+#_5e55b149897cea224b09ae42961de925p2@RXFP2
4.66e-34FFCP PHASE2:Hg19::chr13:32313685..32313699,+#_5e55b149897cea224b09ae42961de925p2@RXFP2
5.96e-34FFCP PHASE1:Hg19::chr1:46379338..46379343,+#_e8387d86bceb276d6eca9b9e93b9f7f4p13@MAST2
5.96e-34FFCP PHASE1:Hg19::chr4:187518318..187518321,-#_e8387d86bceb276d6eca9b9e93b9f7f4p53@FAT1
5.96e-34FFCP PHASE2:Hg19::chr3:132975822..132975848,-#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr3:132975822..132975848, -
5.96e-34FFCP PHASE2:Hg19::chr7:12134356..12134370,-#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr7:12134356..12134370, -
5.96e-34FFCP PHASE1:Hg19::chr11:102712977..102712984,-#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr11:102712977..102712984, -
5.96e-34FFCP PHASE2:Hg19::chr3:132975886..132975894,-#_e8387d86bceb276d6eca9b9e93b9f7f4p1@ENST00000504993
5.96e-34FFCP PHASE2:Hg19::chr11:102712977..102712984,-#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr11:102712977..102712984, -
5.96e-34FFCP PHASE2:Hg19::chr6:130763941..130763951,+#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr6:130763941..130763951, +
5.96e-34FFCP PHASE1:Hg19::chr3:132975822..132975848,-#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr3:132975822..132975848, -
5.96e-34FFCP PHASE1:Hg19::chr7:12134356..12134370,-#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr7:12134356..12134370, -
5.96e-34FFCP PHASE1:Hg19::chr3:132975886..132975894,-#_e8387d86bceb276d6eca9b9e93b9f7f4p1@ENST00000504993
5.96e-34FFCP PHASE2:Hg19::chr1:46379338..46379343,+#_e8387d86bceb276d6eca9b9e93b9f7f4p13@MAST2
5.96e-34FFCP PHASE2:Hg19::chr4:187518318..187518321,-#_e8387d86bceb276d6eca9b9e93b9f7f4p53@FAT1
5.96e-34FFCP PHASE1:Hg19::chr6:130763941..130763951,+#_e8387d86bceb276d6eca9b9e93b9f7f4p@chr6:130763941..130763951, +
9.1e-34FFCP PHASE2:Hg19::chr13:32313658..32313668,+#_8f487ae0828d2248f4966c3b68e5147cp3@RXFP2
9.1e-34FFCP PHASE1:Hg19::chr13:32313658..32313668,+#_8f487ae0828d2248f4966c3b68e5147cp3@RXFP2
8.26e-33FFCP PHASE2:Hg19::chr21:30000326..30000330,+#_9d7b7c6454c09eb44c747bbfbb3ede6fp@chr21:30000326..30000330, +
8.26e-33FFCP PHASE1:Hg19::chr21:30000326..30000330,+#_9d7b7c6454c09eb44c747bbfbb3ede6fp@chr21:30000326..30000330, +
2.41e-32FFCP PHASE2:Hg19::chr6:130761678..130761702,+#_0f8a8b9f093a7f57ad964df0cef34d47p1@AB385516
2.41e-32FFCP PHASE1:Hg19::chr6:130761678..130761702,+#_0f8a8b9f093a7f57ad964df0cef34d47p1@AB385516
1.3e-31FFCP PHASE2:Hg19::chr8:42042654..42042665,-#_0d84b6cb6d4274cec3599224c863d90fp9@PLAT
1.3e-31FFCP PHASE1:Hg19::chr8:42042654..42042665,-#_0d84b6cb6d4274cec3599224c863d90fp9@PLAT
7.37e-31FFCP PHASE2:Hg19::chr2:220326139..220326158,+#_2b7426639d9e6fd5a7d4011f399ec981p10@SPEG
7.37e-31FFCP PHASE1:Hg19::chr2:220326139..220326158,+#_2b7426639d9e6fd5a7d4011f399ec981p10@SPEG
1.0e-30FFCP PHASE1:Hg19::chr7:27219651..27219660,-#_1a1a919887906d488d0224ad569c528cp4@ENST00000470747
1.0e-30FFCP PHASE2:Hg19::chr7:27219651..27219660,-#_1a1a919887906d488d0224ad569c528cp4@ENST00000470747
1.71e-30FFCP PHASE1:Hg19::chr8:42033253..42033264,-#_a1b176c2183f5eec272f4e88a822885ep@chr8:42033253..42033264, -
1.71e-30FFCP PHASE2:Hg19::chr8:42033253..42033264,-#_a1b176c2183f5eec272f4e88a822885ep@chr8:42033253..42033264, -
1.98e-30FFCP PHASE2:Hg19::chr3:141151044..141151053,+#_13e146b5e23075dc2706f908b50c64b7p51@ZBTB38
1.98e-30FFCP PHASE1:Hg19::chr3:141151044..141151053,+#_13e146b5e23075dc2706f908b50c64b7p51@ZBTB38
3.59e-30FFCP PHASE1:Hg19::chr10:90974443..90974454,-#_158552840c619129259e1517cb118a1fp@chr10:90974443..90974454, -
3.59e-30FFCP PHASE2:Hg19::chr10:90974443..90974454,-#_158552840c619129259e1517cb118a1fp@chr10:90974443..90974454, -
8.26e-30FFCP PHASE2:Hg19::chr7:84349931..84349955,-#_84f1f98ac5843e6287279d3f616ef071p@chr7:84349931..84349955, -
8.26e-30FFCP PHASE1:Hg19::chr7:84349931..84349955,-#_84f1f98ac5843e6287279d3f616ef071p@chr7:84349931..84349955, -
1.8e-29FFCP PHASE2:Hg19::chr9:106854088..106854104,-#_b965d825d6ebc60744fe4cdcfd654589p@chr9:106854088..106854104, -
1.8e-29FFCP PHASE1:Hg19::chr9:106854088..106854104,-#_b965d825d6ebc60744fe4cdcfd654589p@chr9:106854088..106854104, -
6.14e-29FFCP PHASE1:Hg19::chr3:98518094..98518105,-#_c265bef2adda44f001946aa79832a573p39@DCBLD2
6.14e-29FFCP PHASE2:Hg19::chr3:98518094..98518105,-#_c265bef2adda44f001946aa79832a573p39@DCBLD2
6.28e-29FFCP PHASE1:Hg19::chr10:90988088..90988122,-#_b67e4e39a465c1282d8a2a78e200f8a8p@chr10:90988088..90988122, -
6.28e-29FFCP PHASE2:Hg19::chr10:90988088..90988122,-#_b67e4e39a465c1282d8a2a78e200f8a8p@chr10:90988088..90988122, -
6.84e-28FFCP PHASE2:Hg19::chr1:219615990..219616001,-#_a494aeff54e576f17ef0f977c280888bp1@ENST00000420762
6.84e-28FFCP PHASE1:Hg19::chr1:219615990..219616001,-#_a494aeff54e576f17ef0f977c280888bp1@ENST00000420762
8.12e-28FFCP PHASE1:Hg19::chr4:6279204..6279216,+#_a8bcc4843b3b6b3588be4dc750ce8a94p6@WFS1
8.12e-28FFCP PHASE2:Hg19::chr4:6279204..6279216,+#_a8bcc4843b3b6b3588be4dc750ce8a94p6@WFS1
9.35e-28FFCP PHASE1:Hg19::chr8:42045498..42045512,-#_f8b8e07cdc4a098de0db0e7596a58cfdp6@PLAT
9.35e-28FFCP PHASE2:Hg19::chr8:42045498..42045512,-#_f8b8e07cdc4a098de0db0e7596a58cfdp6@PLAT
1.06e-27FFCP PHASE2:Hg19::chr6:17281802..17281817,+#_8a70f18409f0a69a8e4de4efcab7d12cp13@RBM24
1.06e-27FFCP PHASE1:Hg19::chr3:151871166..151871172,+#_8a70f18409f0a69a8e4de4efcab7d12cp@chr3:151871166..151871172, +
1.06e-27FFCP PHASE1:Hg19::chr6:17281802..17281817,+#_8a70f18409f0a69a8e4de4efcab7d12cp13@RBM24
1.06e-27FFCP PHASE2:Hg19::chr3:151871166..151871172,+#_8a70f18409f0a69a8e4de4efcab7d12cp@chr3:151871166..151871172, +
1.82e-27FFCP PHASE2:Hg19::chr3:69811826..69811835,+#_d794d01d55ae88b6194aadc7e7056324p16@MITF
1.82e-27FFCP PHASE1:Hg19::chr3:69811826..69811835,+#_d794d01d55ae88b6194aadc7e7056324p16@MITF
2.72e-27FFCP PHASE2:Hg19::chr7:129962463..129962477,+#_b55a8e1aadd03cd1efe67312237d044bp@chr7:129962463..129962477, +
2.72e-27FFCP PHASE1:Hg19::chr7:129962463..129962477,+#_b55a8e1aadd03cd1efe67312237d044bp@chr7:129962463..129962477, +
2.98e-27FFCP PHASE1:Hg19::chr1:163042618..163042628,+#_452ee6838b990b7c594b832e489a9c59p@chr1:163042618..163042628, +
2.98e-27FFCP PHASE2:Hg19::chr1:163042618..163042628,+#_452ee6838b990b7c594b832e489a9c59p@chr1:163042618..163042628, +
3.26e-27FFCP PHASE2:Hg19::chr12:75875762..75875778,+#_8a8932fb87db48ce32aefda63bf48efdp@chr12:75875762..75875778, +
3.26e-27FFCP PHASE1:Hg19::chr12:75875762..75875778,+#_8a8932fb87db48ce32aefda63bf48efdp@chr12:75875762..75875778, +
4.65e-27FFCP PHASE2:Hg19::chr14:76447469..76447487,-#_37c48be25c82c030c87cc9417bbe555fp12@TGFB3
4.65e-27FFCP PHASE1:Hg19::chr14:76447469..76447487,-#_37c48be25c82c030c87cc9417bbe555fp12@TGFB3
5.31e-27FFCP PHASE1:Hg19::chr10:90975757..90975768,-#_b74356c295ce6d6cf5acb1e78b34e80ep@chr10:90975757..90975768, -
5.31e-27FFCP PHASE2:Hg19::chr10:90975757..90975768,-#_b74356c295ce6d6cf5acb1e78b34e80ep@chr10:90975757..90975768, -